newsfilter
← Latest News
Business Wire·

PepGen Announces Issuance of U.S. Patent for Proprietary PGN-EDODM1 Molecule

Composition of matter patent covers the Company's novel PGN-EDODM1 molecule and serves as a cornerstone of its expanding patent portfolio PepGen Inc. (NASDAQ:PEPG), a clinical-stage biotechnology company advancing the